Clinical Trials Browser

Phase 2 × NETWORK × Recurrent Uterine Corpus Sarcoma × Clear all

NCT00114218 2019-01-08

Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer

Phase 2 Completed

28 enrolled 7 charts

GynecologicSarcoma

Recurrent Uterine Corpus Sarcoma

NCT00031629 2016-12-08

Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus

Phase 2 Completed

GynecologicSarcoma

Recurrent Uterine Corpus Sarcoma